Sarang Chitale, who works at Leigh Infirmary near Manchester, has been targeted by a fraudster named Shyam Acharya, who used his identity to enter Australia back in 2003 and register with the medical board in the state of New South Wales (NSW).
According to UK media reports, it is unclear whether the pair met in India in the past.
Asked whether he knew Acharya, Chitale told The Australian newspaper "I know - I cannot talk."
"There is nothing we can do, all we can do is carry on. He has been advised not to talk to anybody while there is an ongoing investigation," she told Sydney's 'Daily Telegraph'.
The case is being investigated by the UK's National Health Service (NHS) and the Australian medical authorities.
Acharya, pretending to be Chitale, has reportedly spent years treating patients in emergency departments at four hospitals across NSW.
The 41-year-old has also acquired Australian citizenship as Chitale.
Health authorities in Australia have been examining records of all patients treated by the fraudster to check whether any were mistreated.
After working for public hospitals until 2014, he worked for the pharmaceutical giant AstraZeneca and Novotech, a medical research company.
Novotech last year became suspicious about his qualifications and alerted local health authorities, which apparently prompted him to flee Australia.
Acharya's present whereabouts are unknown.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
